Clinical Trials
4 trialsNCT03878849 2025-08-28
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Allarity Therapeutics
Phase 2 Recruiting
NCT05775549 2024-09-20
FLAME
AstraZeneca
Completed
NCT05794659 2023-07-20
Cornerstone4
Aston Sci. Inc.
Phase 2 Not yet recruiting
NCT04556539 2021-05-12
Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 2 Unknown